Vimarsana
Biggest News Aggregation in the World

Robertv Baumgartner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertv Baumgartner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertv Baumgartner Today - Breaking & Trending Today

New Mexico Educational Retirement Board Sells 100 Shares of Bio-Techne Co. (NASDAQ:TECH) - Vimarsana News

New Mexico Educational Retirement Board Sells 100 Shares of Bio-Techne Co. (NASDAQ:TECH)

New Mexico Educational Retirement Board trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 4.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,300 shares of the biotechnology company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings […]

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at Zacks Investment Research - Vimarsana News

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at Zacks Investment Research

Bio-Techne (NASDAQ:TECH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm currently has a $408.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.79% from […]

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Buy" from Analysts - Vimarsana News

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. […]

Bio-Techne (NASDAQ:TECH) Cut to Hold at Zacks Investment Research - Vimarsana News

Bio-Techne (NASDAQ:TECH) Cut to Hold at Zacks Investment Research

Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It […]

Bio-Techne (TECH) – Analysts' Recent Ratings Updates - Vimarsana News

Bio-Techne (TECH) – Analysts' Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Bio-Techne (NASDAQ: TECH): 5/12/2022 – Bio-Techne was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $394.00 price target on the stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It […]